A Multi-Center Retrospective Analysis Examining the Effect of Dipeptidyl Peptidase-4 Inhibitors on Progression-Free Survival in Patients With Prostate Cancer

por Pan, Kelsey, Skelton, William P, Elzeneini, Mohammed, Nguyen, Thu-Cuc, Franke, Aaron J, Ali, Azka, Bishnoi, Rohit, Dang, Long, Dang, Nam H, Kish, Julie
Publicado 2021

Patient choice for high‐volume center radiation impacts head and neck cancer outcome

por Naghavi, Arash O., Echevarria, Michelle I., Strom, Tobin J., Abuodeh, Yazan A., Venkat, Puja S., Ahmed, Kamran A., Demetriou, Stephanie, Frakes, Jessica M., Kim, Youngchul, Kish, Julie A., Russell, Jeffery S., Otto, Kristen J., Chung, Christine H., Harrison, Louis B., Trotti, Andy, Caudell, Jimmy J.
Publicado 2018

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II St...

por Chung, Christine H., Bonomi, Marcelo, Steuer, Conor E., Li, Jiannong, Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Song, Feifei, Hernandez-Prera, Juan C., Wenig, Bruce M., Molina, Helen, Farinhas, Joaquim M., McMullen, Caitlin P., Wadsworth, J. Trad, Patel, Krupal B., Kish, Julie A., Muzaffar, Jameel, Kirtane, Kedar, Rocco, James W., Schell, Michael J., Saba, Nabil F.
Publicado 2021